Real-world experience with selinexor-containing chemotherapy-free or low-dose chemotherapy regimens for patients with relapsed/refractory acute myeloid leukemia and myeloid sarcoma

• Main Authors: Xiwen Tong (Author), Jie Jin (Author), Bin Xu (Author), Shuai Su (Author), Li Li (Author), Mengyuan Li (Author), Yizhou Peng (Author), Xia Mao (Author), Wei Huang (Author), Donghua Zhang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Treatment of relapsed or refractory acute myeloid leukemia (R/R AML) and myeloid sarcoma (MS) has presented challenges for decades. Studies on selinexor in combination with various standard or intensive chemotherapy regimens for the treatment of R/R AML have demonstrated promising resu...